Published in Monoclonal Antibodies Weekly, February 2nd, 2000
"Recent reports have shown altered expression of CD44 in renal cell carcinomas," wrote M. Z. Gilcrease and colleagues from the University of Texas, SW Medical School, Texas. "However, to our knowledge there are no data correlating CD44 expression in renal cell carcinomas with subsequent turner progression or recurrence, nor is there information about the presence of particular splice variants of CD44 in these tumors."
The authors examined the immunohistochemical expression of CD44S, the standard isoform of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Monoclonal Antibodies Weekly